1887

Abstract

Platelets have been reported to become activated in response to bacteria and this is proposed to contribute to the acute response to bacterial infection. In the present study, we investigated platelet aggregation in response to group G streptococci (GGS) in healthy human donors and in a mouse model of streptococcal sepsis. Platelet aggregation by GGS was dependent on the bacterial surface protein FOG and engagement of the platelet fibrinogen receptor; however, it was independent of IgG and the platelet Fc receptor. Platelets exerted no antibacterial effects on the bacteria, and aggregates formed were markedly unstable, allowing bacteria to rapidly return to the plasma and grow post-aggregation. Thrombocytopenia and platelet activation occurred during invasive infection with GGS, and platelets were demonstrated to contribute to bacterial dissemination during infection. These findings reveal an important role for bacteria–platelet interactions during the pathogenesis of streptococcal infection.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.000203
2016-01-01
2021-07-30
Loading full text...

Full text loading...

/deliver/fulltext/micro/162/1/117.html?itemId=/content/journal/micro/10.1099/mic.0.000203&mimeType=html&fmt=ahah

References

  1. Akinosoglou K., Alexopoulos D. 2014; Use of antiplatelet agents in sepsis: a glimpse into the future. Thromb Res 133:131–138 [View Article][PubMed]
    [Google Scholar]
  2. Arman M., Krauel K. 2015; Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis. J Thromb Haemost 13:893–908 [View Article][PubMed]
    [Google Scholar]
  3. Bekker V., Bijlsma M. W., van de Beek D., Kuijpers T. W., van der Ende A. 2014; Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis 14:1083–1089 [View Article][PubMed]
    [Google Scholar]
  4. Bergmann R., Nitsche-Schmitz D. P. 2015; Small plasmids in Streptococcus dysgalactiae subsp., equisimilis isolated from human infections in southern India and sequence analysis of two novel plasmids. Int J Med Microbiol 305:365–369 [View Article][PubMed]
    [Google Scholar]
  5. Björck L., Kronvall G. 1984; Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 133:969–974[PubMed]
    [Google Scholar]
  6. Brandt C. M., Spellerberg B. 2009; Human infections due to Streptococcus dysgalactiae subspecies equisimilis . Clin Infect Dis 49:766–772 [View Article][PubMed]
    [Google Scholar]
  7. Carapetis J. R., Steer A. C., Mulholland E. K., Weber M. 2005; The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694 [View Article][PubMed]
    [Google Scholar]
  8. Carlsson F., Sandin C., Lindahl G. 2005; Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol 56:28–39 [View Article][PubMed]
    [Google Scholar]
  9. Coller B. S. 1995; Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 92:2373–2380 [View Article][PubMed]
    [Google Scholar]
  10. Cunningham M. W. 2000; Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470–511 [View Article][PubMed]
    [Google Scholar]
  11. de Stoppelaar S. F., van't Veer C., Claushuis T.A.M., Albersen B.J.A., Roelofs J.J.T.H., van der Poll T. 2014; Thrombocytopenia impairs host defense in Gram-negative pneumonia-derived sepsis in mice. Blood 124:3781–3790 [View Article][PubMed]
    [Google Scholar]
  12. Egesten A., Frick I. M., Mörgelin M., Olin A. I., Björck L. 2011; Binding of albumin promotes bacterial survival at the epithelial surface. J Biol Chem 286:2469–2476 [View Article][PubMed]
    [Google Scholar]
  13. Heath P. T., Jardine L. A. 2014; Neonatal infections: group B streptococcus. BMJ Clinical Evidence Systematic Review323 http://clinicalevidence.bmj.com/x/systematic-review/0323/overview.html /
    [Google Scholar]
  14. Hui P., Cook D. J., Lim W., Fraser G. A., Arnold D. M. 2011; The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139:271–278 [View Article][PubMed]
    [Google Scholar]
  15. Johansson H. M., Mörgelin M., Frick I. M. 2004; Protein FOG – a streptococcal inhibitor of neutrophil function. Microbiology 150:4211–4221 [View Article][PubMed]
    [Google Scholar]
  16. Johansson B. P., Shannon O., Björck L. 2008; IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One 3:e1692 [CrossRef]
    [Google Scholar]
  17. Johansson D., Shannon O., Rasmussen M. 2011; Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One 6:e26928 [View Article][PubMed]
    [Google Scholar]
  18. Kahn F., Hmiscey S., Shannon O. 2013; Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis. Microbes Infect 15:669–676 [View Article][PubMed]
    [Google Scholar]
  19. Kato Y., Hori S., Fujita N., Tsuruo T. 1998; A novel anti-platelet monoclonal antibody induces mouse platelet aggregation through an Fc receptor-independent mechanism. Biochem Biophys Res Commun 242:250–255 [View Article][PubMed]
    [Google Scholar]
  20. Kerrigan S. W., Cox D. 2010; Platelet-bacterial interactions. Cell Mol Life Sci 67:513–523 [View Article][PubMed]
    [Google Scholar]
  21. Lancefield R. C. 1933; A serological differentiation of human and other groups of haemolytic streptococci. J Exp Med 57:571–595 [View Article][PubMed]
    [Google Scholar]
  22. Levi M. 2005; Platelets in sepsis. Hematology 10:(Suppl. 1)129–131 [View Article][PubMed]
    [Google Scholar]
  23. McKenzie S. E., Taylor S. M., Malladi P., Yuhan H., Cassel D. L., Chien P., Schwartz E., Schreiber A. D., Surrey S., Reilly M. P. 1999; The role of the human Fc receptor FcγRIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol 162:4311–4318[PubMed]
    [Google Scholar]
  24. Nitsche-Schmitz D. P., Johansson H. M., Sastalla I., Reissmann S., Frick I. M., Chhatwal G. S. 2007; Group G streptococcal IgG binding molecules FOG and protein G have different impacts on opsonization by C1q. J Biol Chem 282:17530–17536 [View Article][PubMed]
    [Google Scholar]
  25. Otto G. P., Sossdorf M., Boettel J., Kabisch B., Breuel H., Winning J., Lösche W. 2013; Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock. Platelets 24:480–485 [View Article][PubMed]
    [Google Scholar]
  26. Semple J. W., Italiano J. E. Jr, Freedman J. 2011; Platelets and the immune continuum. Nat Rev Immunol 11:264–274 [View Article][PubMed]
    [Google Scholar]
  27. Sharron M., Hoptay C. E., Wiles A. A., Garvin L. M., Geha M., Benton A. S., Nagaraju K., Freishtat R. J. 2012; Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade. PLoS One 7:e41549 [View Article][PubMed]
    [Google Scholar]
  28. Svensson L., Baumgarten M., Mörgelin M., Shannon O. 2014; Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates from which bacteria subsequently escape. Infect Immun 82:4307–4313 [CrossRef]
    [Google Scholar]
  29. Takahashi T., Sunaoshi K., Sunakawa K., Fujishima S., Watanabe H., Ubukata K., the Invasive Streptococcal Disease Working Group. 2010; Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp., equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections. Clin Microbiol Infect 16:1097–1103 [View Article][PubMed]
    [Google Scholar]
  30. Vandijck D. M., Blot S. I., De Waele J. J., Hoste E. A., Vandewoude K. H., Decruyenaere J. M. 2010; Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 39:21–26 [View Article][PubMed]
    [Google Scholar]
  31. Watanabe S., Kirikae T., Miyoshi-Akiyama T. 2013; Complete genome sequence of Streptococcus dysgalactiae subsp equisimilis 167 carrying Lancefield group C antigen and comparative genomics of S. dysgalactiae subsp. equisimilis strains. Genome Biol Evol 5:1644–1651 [View Article][PubMed]
    [Google Scholar]
  32. Winning J., Reichel J., Eisenhut Y., Hamacher J., Kohl M., Deigner H. P., Claus R. A., Bauer M., Lösche W. 2009; Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets 20:50–57 [View Article][PubMed]
    [Google Scholar]
  33. Wollein Waldetoft K., Svensson L., Mörgelin M., Olin A. I., Nitsche-Schmitz D. P., Björck L., Frick I. M. 2012; Streptococcal surface proteins activate the contact system and control its antibacterial activity. J Biol Chem 287:25010–25018 [View Article][PubMed]
    [Google Scholar]
  34. Xiang B., Zhang G., Guo L., Li X. A., Morris A. J., Daugherty A., Whiteheart S. W., Smyth S. S., Li Z. 2013; Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun 4:2657 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.000203
Loading
/content/journal/micro/10.1099/mic.0.000203
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error